{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:04:39Z","timestamp":1795100679302,"version":"4.10.3"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugalcdep.2017.03.030","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T13:55:23Z","timestamp":1496238923000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"special_numbering":"C","title":["Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress"],"prefix":"10.1016","volume":"177","author":[{"given":"Emma","family":"Childs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA, American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0010","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-011-2374-5","article-title":"Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition","volume":"219","author":"Ballard","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0020","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1177\/0269881112446530","article-title":"Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images","volume":"26","author":"Ballard","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pnpbp.2012.02.006","article-title":"Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission","volume":"38","author":"Bambico","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1369-1600.2011.00427.x","article-title":"Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers","volume":"18","author":"Bedi","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cpt1979254440","article-title":"Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms","volume":"25","author":"Benowitz","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hup.2374","article-title":"Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report","volume":"29","author":"Bergamaschi","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-002-1144-9","article-title":"Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol","volume":"163","author":"Berrendero","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0050","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","article-title":"The endocannabinoid system and emotional processing: a pharmacological fMRI study with \u03949-tetrahydrocannabinol","volume":"23","author":"Bossong","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejphar.2006.10.038","article-title":"5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404 the anandamide transport inhibitor, in Sprague-Dawley rats","volume":"555","author":"Braida","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0376-8716(88)90068-3","article-title":"Effects of marijuana on the task-elicited physiological response","volume":"21","author":"Capriotti","year":"1988","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0065","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1469-8986.2009.00961.x","article-title":"Cardiovascular, hormonal, and emotional responses to the TSST in relation to sex and menstrual cycle phase","volume":"47","author":"Childs","year":"2010","journal-title":"Psychophysiology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007691-199312000-00013","article-title":"Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage","volume":"15","author":"Cone","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0080","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","article-title":"Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users","volume":"164","author":"Curran","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0095","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.mp.4000812","article-title":"The amygdala: vigilance and emotion","volume":"6","author":"Davis","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1037\/0033-2909.130.3.355","article-title":"Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research","volume":"130","author":"Dickerson","year":"2004","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.psyneuen.2005.02.001","article-title":"Psychological determinants of the cortisol stress response: the role of anticipatory cognitive appraisal","volume":"30","author":"Gaab","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.psyneuen.2014.05.023","article-title":"Neuroendocrine and cardiovascular reactions to acute psychological stress are attenuated in smokers","volume":"48","author":"Ginty","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/00952990.2011.600398","article-title":"CB1 \u2212 cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men","volume":"38","author":"Goodwin","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0893-133X(01)00273-1","article-title":"Effects of acute smoked marijuana on complex cognitive performance","volume":"25","author":"Hart","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-002-1231-y","article-title":"Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans","volume":"164","author":"Hart","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.pnpbp.2009.11.001","article-title":"Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids","volume":"34","author":"Hill","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0150","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1007\/s00213-014-3630-2","article-title":"Acute subjective effects after smoking joints containing up to 69 mg (9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial","volume":"231","author":"Hunault","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0155","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jsat.2008.08.005","article-title":"Stress-related factors in cannabis use and misuse: implications for prevention and treatment","volume":"36","author":"Hyman","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00433061","article-title":"Drug preference and mood in humans: diazepam","volume":"71","author":"Johanson","year":"1980","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/002204268601600103","article-title":"Why do the nation\u2019s students use drugs and alcohol? Self-reported reasons from nine national surveys","volume":"16","author":"Johnston","year":"1986","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0170","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1002\/j.1552-4604.2002.tb06004.x","article-title":"Cardiovascular system effects of marijuana","volume":"42","author":"Jones","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1373\/clinchem.2010.152439","article-title":"Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration","volume":"57","author":"Karschner","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-540-88955-7_3","article-title":"Endocannabinoid receptors: CNS localization of the CB(1) cannabinoid receptor","volume":"1","author":"Katona","year":"2009","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(98)00264-0","article-title":"Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users","volume":"63","author":"Kirk","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000119004","article-title":"The \u2018Trier Social Stress Test'? A tool for investigating psychobiological stress responses in a laboratory setting","volume":"28","author":"Kirschbaum","year":"1993","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0200","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.addbeh.2006.09.010","article-title":"Marijuana motives: young adults' reasons for using marijuana","volume":"32","author":"Lee","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0210","series-title":"Profile of Mood States","author":"McNair","year":"1971"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00436092","article-title":"Simulated public speaking as a model of clinical anxiety","volume":"77","author":"McNair","year":"1982","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0225","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0230","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.5603-07.2008","article-title":"Cannabinoid modulation of amygdala reactivity to social signals of threat in humans","volume":"28","author":"Phan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0235","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00702-011-0747-x","article-title":"Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect","volume":"119","author":"Rabinak","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0240","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00213-008-1422-2","article-title":"The effects of cannabinoids on serum cortisol and prolactin in humans","volume":"203","author":"Ranganathan","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0245","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2013.05.007","article-title":"Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women","volume":"109","author":"Roche","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0255","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1037\/a0021148","article-title":"The Perceived Stress Reactivity Scale Measurement invariance, stability, and validity in three countries","volume":"23","author":"Schlotz","year":"2011","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0260","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3109\/10826088209056344","article-title":"Patterns of reasons for drug use among detained and adjudicated juveniles","volume":"17","author":"Segal","year":"1982","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0265","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1002\/j.1552-4604.2002.tb06005.x","article-title":"Cardiovascular consequences of marijuana use","volume":"42","author":"Sidney","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0306-4603(98)00104-X","article-title":"A comparison of motives for marijuana and alcohol use among experienced users","volume":"25","author":"Simons","year":"2000","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0275","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","article-title":"Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans","volume":"161","author":"Wachtel","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0290","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.03.030_bib0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161730220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161730220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:52:38Z","timestamp":1750269158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161730220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":59,"alternative-id":["S037687161730220X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.030","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}